Combined use of emapalumab and ruxolitinib in a patient with refractory hemophagocytic lymphohistiocytosis was safe and effective

Michael P. Triebwasser, David M. Barrett, Hamid Bassiri, Nancy Bunin, Caitlin Elgarten, Jason Freedman, Abdallah S. Geera, Dimitri Monos, Michele P. Lambert, Timothy Olson, Alix E. Seif, Michele Paessler, Whitney Petrosa, Anne F. Reilly, Neil Romberg, Kathleen E. Sullivan, Ghazal Z. Quinn, Edward Behrens, David T. Teachey

Research output: Contribution to journalLetterpeer-review

9 Scopus citations
Original languageEnglish
Article numbere29026
JournalPediatric Blood and Cancer
Issue number7
StatePublished - Jul 2021
Externally publishedYes

Cite this